|
| 37522255 | Advancing specificity in delirium: The delirium subtyping initiative. | Alzheimers Dement | 2024 |
| 36928014 | Are There Distinct Cardiovascular Subclasses in Acute Respiratory Distress Syndrome? Maybe. | Crit Care Med | 2023 |
| 37633303 | Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. | Lancet Respir Med | 2023 |
| 37888913 | Simvastatin in Critically Ill Patients with Covid-19. | N Engl J Med | 2023 |
| 37695136 | Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials. | Crit Care Med | 2023 |
| 37495364 | Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials. | Thorax | 2023 |
| 37312169 | Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis. | Crit Care | 2023 |
| 37311208 | Subphenotypes Assigned to Pediatric Acute Respiratory Failure Patients Show Differing Outcomes. | Am J Respir Crit Care Med | 2023 |
| 37378460 | Analysis of Protein Biomarkers From Hospitalized COVID-19 Patients Reveals Severity-Specific Signatures and Two Distinct Latent Profiles With Differential Responses to Corticosteroids. | Crit Care Med | 2023 |
| 36656551 | Tight Glycemic Control, Inflammation, and the ICU: Evidence for Heterogeneous Treatment Effects in Two Randomized Controlled Trials. | Am J Respir Crit Care Med | 2023 |
| 36877594 | Individualized Treatment Effects of Bougie versus Stylet for Tracheal Intubation in Critical Illness. | Am J Respir Crit Care Med | 2023 |
| 36648136 | Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS. | Am J Physiol Lung Cell Mol Physiol | 2023 |
| 36469902 | Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome. | Annu Rev Med | 2023 |
| 36732621 | Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles. | Nat Biomed Eng | 2023 |
| 34253679 | Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study. | Thorax | 2022 |
| 35615241 | Covid-19 ICU remote-learning course (CIRLC): Rapid ICU remote training for frontline health professionals during the COVID-19 pandemic in the UK. | J Intensive Care Soc | 2022 |
| 35641002 | Ventilatory Ratio Is a Valuable Prognostic Indicator in an Observational Cohort of Patients With ARDS. | Respir Care | 2022 |
| 36479445 | Multistate Modeling of Clinical Trajectories and Outcomes in the ICU: A Proof-of-Concept Evaluation of Acute Kidney Injury Among Critically Ill Patients With COVID-19. | Crit Care Explor | 2022 |
| 36202054 | Hospital trajectories and early predictors of clinical outcomes differ between SARS-CoV-2 and influenza pneumonia. | EBioMedicine | 2022 |
| 36266337 | Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults. | Nat Microbiol | 2022 |
| 36057279 | Opportunities for improved clinical trial designs in acute respiratory distress syndrome. | Lancet Respir Med | 2022 |
| 34883088 | Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. | Lancet Respir Med | 2022 |
| 35274164 | Towards a biological definition of ARDS: are treatable traits the solution? | Intensive Care Med Exp | 2022 |
| 35176550 | Cutting the Gordian knot of heterogeneity: Can integrated systems biology modelling rescue critical care syndromes? | EBioMedicine | 2022 |
| 35026177 | Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. | Lancet Respir Med | 2022 |
| 35050845 | Cigarette Smoke Exposure and Acute Respiratory Distress Syndrome in Sepsis: Epidemiology, Clinical Features, and Biologic Markers. | Am J Respir Crit Care Med | 2022 |
| 34818142 | Reply to Kuindersma and Spronk: Time to Tailor the One-Size-Fits-All Approach? | Am J Respir Crit Care Med | 2022 |
| 34112703 | Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial. | Thorax | 2022 |
| 33351077 | The Clinical Course of Coronavirus Disease 2019 in a US Hospital System: A Multistate Analysis. | Am J Epidemiol | 2021 |
| 34861492 | Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials. | EBioMedicine | 2021 |
| 34548134 | Pathophysiology of the Acute Respiratory Distress Syndrome: Insights from Clinical Studies. | Crit Care Clin | 2021 |
| 34543591 | Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids. | Am J Respir Crit Care Med | 2021 |
| 34652268 | A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement. | Am J Respir Crit Care Med | 2021 |
| 34015326 | Immunotherapy in COVID-19: why, who, and when? | Lancet Respir Med | 2021 |
| 34345827 | Plasma Metabolites in Early Sepsis Identify Distinct Clusters Defined by Plasma Lipids. | Crit Care Explor | 2021 |
| 34173858 | Genome-wide association studies in ARDS: SNPing the tangled web of heterogeneity. | Intensive Care Med | 2021 |
| 33460572 | Assessing the importance of interleukin-6 in COVID-19 - Authors' reply. | Lancet Respir Med | 2021 |
| 33142075 | Biological Mechanisms of Cognitive and Physical Impairments after Critical Care. Rethinking the Inflammatory Model? | Am J Respir Crit Care Med | 2021 |
| 33165028 | Practitioner's Guide to Latent Class Analysis: Methodological Considerations and Common Pitfalls. | Crit Care Med | 2021 |
| 33355521 | A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis. | Am J Physiol Lung Cell Mol Physiol | 2021 |
| 32482788 | The perils of premature phenotyping in COVID-19: a call for caution. | Eur Respir J | 2020 |
| 31948926 | Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. | Lancet Respir Med | 2020 |
| 33075298 | Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. | Lancet Respir Med | 2020 |
| 33156382 | Current and evolving standards of care for patients with ARDS. | Intensive Care Med | 2020 |
| 33044866 | Using best subset regression to identify clinical characteristics and biomarkers associated with sepsis-associated acute kidney injury. | Am J Physiol Renal Physiol | 2020 |
| 33206201 | Phenotypes and personalized medicine in the acute respiratory distress syndrome. | Intensive Care Med | 2020 |
| 32861275 | Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. | Lancet Respir Med | 2020 |
| 32747393 | Response to COVID-19 phenotyping correspondence. | Eur Respir J | 2020 |
| 32602883 | Is a "Cytokine Storm" Relevant to COVID-19? | JAMA Intern Med | 2020 |
| 32766536 | Contact tracing: Can 'Big tech' come to the rescue, and if so, at what cost? | EClinicalMedicine | 2020 |